ADC TOXICITY ATLAS
← Atlas

Molecular targets

The 98 ADCs grouped by the 50 antigens they bind. Each box gives the eye-tissue target-expression rates (Human Cell Atlas detection, HPA bulk RNA) and every ADC against that target - ranked by ocular burden, so on-target expression can be read against observed ocular toxicity.

ERBB2
HER2
Receptor tyrosine kinase
12 ADCs42.8% mean ocular
Eye-tissue target expression
Cornea
46.2 %
Conjunctiva
61.13 %
RPE
5.48 %
Retina
7.5 nTPM
100A166Auristatin94.7DP-303cAuristatin78.1Trastuzumab duocarmazineDNA alkylator60ZV0203Auristatin55.3FS-1502Auristatin46.4ARX788Auristatin45Zanidatamab zovodotin (ZW49)Auristatin11Trastuzumab deruxtecanTopoisomerase I inhibitor9.5PF-06804103Auristatin5Disitamab vedotinAuristatin5Trastuzumab emtansineMaytansinoid3.3Trastuzumab rezetecanTopoisomerase I inhibitor
full details →
FOLR1
Folate receptor alpha (FRalpha / FOLR1)
GPI-anchored
5 ADCs13.6% mean ocular
Eye-tissue target expression
Cornea
0.02 %
Conjunctiva
0.19 %
RPE
3.21 %
Retina
0.4 nTPM
59Mirvetuximab soravtansineMaytansinoid9Farletuzumab ecteribulinMicrotubule (other)0BAT-8006Topoisomerase I inhibitor0Farletuzumab (naked Ab)-0Rinatabart sesutecanTopoisomerase I inhibitor
full details →
TACSTD2
Tumor-associated calcium signal transducer 2 (TROP-2)
TACSTD / EpCAM-TROP
5 ADCs10.4% mean ocular
Eye-tissue target expression
Cornea
65.43 %
Conjunctiva
86.39 %
RPE
0 %
Retina
0 nTPM
38Datopotamab deruxtecanTopoisomerase I inhibitor6.5PF-06664178Auristatin5Sacituzumab govitecanTopoisomerase I inhibitor2.3Sacituzumab tirumotecanTopoisomerase I inhibitor0BAT-8008Topoisomerase I inhibitor
full details →
TNFRSF17
BCMA (B-cell maturation antigen)
TNF receptor superfamily
4 ADCs43.9% mean ocular
Eye-tissue target expression
Cornea
0.4 %
Conjunctiva
0.06 %
RPE
0 %
Retina
0.1 nTPM
92Belantamab mafodotinAuristatin53.7MEDI2228PBD dimer30AMG-224Maytansinoid0HDP-101Amatoxin
full details →
CD19
CD19
Immunoglobulin superfamily
4 ADCs41.3% mean ocular
Eye-tissue target expression
Cornea
0 %
Conjunctiva
0 %
RPE
0.05 %
Retina
0 nTPM
84Denintuzumab mafodotin (NHL)Auristatin56Denintuzumab mafodotin (ALL)Auristatin25Coltuximab ravtansineMaytansinoid0Loncastuximab tesirinePBD dimer
full details →
EGFR
Epidermal growth factor receptor (EGFR; ErbB1/HER1)
Receptor tyrosine kinase
4 ADCs27.3% mean ocular
Eye-tissue target expression
Cornea
89.35 %
Conjunctiva
93.02 %
RPE
83.36 %
Retina
9.4 nTPM
94Depatuxizumab mafodotinAuristatin8AVID-100Maytansinoid7Serclutamab talirine (ABBV-321, EGFR, PBD/SGD-1882)PBD dimer0Cetuximab saratolacanPhotosensitizer
full details →
CD22
CD22
Siglec
4 ADCs12.4% mean ocular
Eye-tissue target expression
Cornea
0.5 %
Conjunctiva
1.64 %
RPE
1.16 %
Retina
0 nTPM
31TRPH-222Maytansinoid9.5Pinatuzumab vedotinAuristatin9Moxetumomab pasudotoxOther0Inotuzumab ozogamicinCalicheamicin
full details →
F3
Tissue factor (coagulation factor III, CD142)
Other
3 ADCs41.3% mean ocular
Eye-tissue target expression
Cornea
8.16 %
Conjunctiva
66.36 %
RPE
51.39 %
Retina
67.1 nTPM
55Tisotumab vedotinAuristatin42XB-002 (Samatatug zovodotin)Auristatin27MRG-004AAuristatin
full details →
MET
Hepatocyte growth factor receptor (MET / c-MET)
Receptor tyrosine kinase
3 ADCs24% mean ocular
Eye-tissue target expression
Cornea
26.59 %
Conjunctiva
67.14 %
RPE
59.48 %
Retina
3.6 nTPM
47MYTX-011Auristatin25Telisotuzumab vedotinAuristatin0BYON-3521Duocarmycin
full details →
MSLN
Mesothelin
GPI-anchored
3 ADCs15.7% mean ocular
Eye-tissue target expression
Cornea
13.34 %
Conjunctiva
55.48 %
RPE
-
Retina
0.6 nTPM
37Anetumab ravtansineMaytansinoid10BMS-986148Tubulysin0DMOT4039AAuristatin
full details →
CLDN18
Claudin-18.2 (CLDN18.2)
Claudin / tight-junction
3 ADCs7.1% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
21.2SYSA-1801Auristatin0ATG-022Auristatin0XNW-27011Topoisomerase I inhibitor
full details →
ENPP3
ENPP3 (CD203c)
Ectonucleotidase
2 ADCs58% mean ocular
Eye-tissue target expression
Cornea
2.79 %
Conjunctiva
5.7 %
RPE
-
Retina
0.3 nTPM
85AGS-16C3FAuristatin31AGS-16M8FAuristatin
full details →
NECTIN4
Nectin-4
Nectin / Ig-CAM
2 ADCs53% mean ocular
Eye-tissue target expression
Cornea
71.38 %
Conjunctiva
56.73 %
RPE
0.33 %
Retina
0 nTPM
66CRB-701 (SYS6002)Auristatin40Enfortumab vedotinAuristatin
full details →
CD70
CD70 (CD27 ligand / CD27L / TNFSF7)
TNF receptor superfamily
2 ADCs51.7% mean ocular
Eye-tissue target expression
Cornea
0.82 %
Conjunctiva
0.64 %
RPE
-
Retina
0 nTPM
57Vorsetuzumab mafodotinAuristatin46.3ARX-305Auristatin
full details →
SLC34A2
NaPi2b (sodium-dependent phosphate transport protein 2B)
SLC transporter
2 ADCs30.5% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
41Upifitamab rilsodotinAuristatin20Lifastuzumab vedotinAuristatin
full details →
TPBG
Trophoblast glycoprotein (5T4)
Other
2 ADCs24.3% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
38.5PF-06263507Auristatin10JK-06Auristatin
full details →
CD79B
CD79B
Immunoglobulin superfamily
2 ADCs24.1% mean ocular
Eye-tissue target expression
Cornea
0 %
Conjunctiva
0 %
RPE
-
Retina
0 nTPM
47Iladatuzumab vedotinAuristatin1.2Polatuzumab vedotinAuristatin
full details →
CEACAM5
Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5 / CEA)
Nectin / Ig-CAM
2 ADCs19% mean ocular
Eye-tissue target expression
Cornea
0.03 %
Conjunctiva
10.55 %
RPE
0 %
Retina
0 nTPM
38Tusamitamab ravtansineMaytansinoid0M-9140Topoisomerase I inhibitor
full details →
DLL3
Delta-like protein 3 (DLL3)
Notch ligand
2 ADCs1.7% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
2.9SC-002 (rovalpituzumab, DLL3, PBD/SG3199)PBD dimer0.54Rovalpituzumab tesirinePBD dimer
full details →
CD33
CD33
Siglec
2 ADCs0% mean ocular
Eye-tissue target expression
Cornea
0.07 %
Conjunctiva
0.06 %
RPE
0.46 %
Retina
0.2 nTPM
0Gemtuzumab ozogamicinCalicheamicin0Vadastuximab talirinePBD dimer
full details →
ADAM9
Disintegrin and metalloproteinase domain-containing protein 9 (ADAM9)
Receptor tyrosine kinase
1 ADC77.8% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
77.8IMGC-936Maytansinoid
full details →
CCR7
C-C chemokine receptor type 7 (CCR7)
GPCR
1 ADC56.3% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
56.3JBH-492Maytansinoid
full details →
MUC1
CanAg (CA242), a sialylated carbohydrate epitope on MUC1
Mucin
1 ADC50% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
50Cantuzumab ravtansineMaytansinoid
full details →
ALCAM
ALCAM (CD166)
Nectin / Ig-CAM
1 ADC49% mean ocular
Eye-tissue target expression
Cornea
5.87 %
Conjunctiva
59.71 %
RPE
-
Retina
3.3 nTPM
49Praluzatamab ravtansineMaytansinoid
full details →
FGFR2
FGFR2
Receptor tyrosine kinase
1 ADC40% mean ocular
Eye-tissue target expression
Cornea
58.38 %
Conjunctiva
74.29 %
RPE
-
Retina
0.7 nTPM
40Aprutumab ixadotinAuristatin
full details →
MUC1 (CA6 epitope carried on MUC1)
CA6 sialoglycotope (MUC1-associated tumor carbohydrate antigen) -- NOTE: not carbonic anhydrase 6
Mucin
1 ADC36% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
36SAR-566658Maytansinoid
full details →
SLITRK6
SLIT and NTRK-like protein 6 (SLITRK6)
Other
1 ADC29% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
29Sirtratumab vedotinAuristatin
full details →
LRRC15
LRRC15 (leucine-rich repeat-containing protein 15)
Other
1 ADC24.4% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
24.4Samrotamab vedotin (ABBV-085)Auristatin
full details →
CD276
B7-H3 (CD276)
Immunoglobulin superfamily
1 ADC19.8% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
19.8Vobramitamab duocarmazineDuocarmycin
full details →
FGFR3
Fibroblast growth factor receptor 3
Receptor tyrosine kinase
1 ADC12% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
12LY3076226 (IMC-D11)Maytansinoid
full details →
VEGFA
Vascular endothelial growth factor A (VEGF-A)
Other
1 ADC10% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
10AB-160Taxane
full details →
LY6E
Lymphocyte antigen 6E (LY6E)
GPI-anchored
1 ADC10% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
10DLYE5953A (RG-7841)Auristatin
full details →
EFNA4
Ephrin-A4
Receptor tyrosine kinase
1 ADC8% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
8PF-06647263Calicheamicin
full details →
SDC1
Syndecan-1 (CD138)
Other
1 ADC6.3% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
6.3Indatuximab ravtansineMaytansinoid
full details →
SLC39A6
LIV-1 (Zinc transporter ZIP6 / SLC39A6)
Receptor tyrosine kinase
1 ADC5.9% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
5.9BRY-812Auristatin
full details →
LY75
Lymphocyte antigen 75 (CD205 / DEC-205)
Other
1 ADC5.9% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
5.9MEN-1309 (OBT076)Maytansinoid
full details →
TNFRSF8
CD30
TNF receptor superfamily
1 ADC5% mean ocular
Eye-tissue target expression
Cornea
0.56 %
Conjunctiva
0.56 %
RPE
1.16 %
Retina
0 nTPM
5Brentuximab vedotinAuristatin
full details →
NOTCH3
Neurogenic locus notch homolog protein 3 (Notch3)
Notch ligand
1 ADC5% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
5PF-06650808Auristatin
full details →
NCAM1
NCAM1 (CD56)
Nectin / Ig-CAM
1 ADC4.7% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
4.7Lorvotuzumab mertansineMaytansinoid
full details →
ERBB3
HER3
Receptor tyrosine kinase
1 ADC2.7% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
2.7Patritumab deruxtecanTopoisomerase I inhibitor
full details →
IL2RA
CD25 (IL-2 receptor subunit alpha / IL2RA)
Cytokine receptor
1 ADC0.9% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
0.9Camidanlumab tesirinePBD dimer
full details →
CEACAM5; CEACAM6
N256-glycosylated CEACAM5 and CEACAM6 (shared tumor-specific glyco-epitope)
Nectin / Ig-CAM
1 ADC0% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
0EBC-129Auristatin
full details →
CD46
Membrane cofactor protein (CD46)
Other
1 ADC0% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
0FOR-46Auristatin
full details →
GPNMB
GPNMB
Other
1 ADC0% mean ocular
Eye-tissue target expression
Cornea
1.48 %
Conjunctiva
49.3 %
RPE
-
Retina
-
0Glembatumumab vedotinAuristatin
full details →
GUCY2C
Guanylyl cyclase C (GCC)
Other
1 ADC0% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
0Indusatumab vedotinAuristatin
full details →
SEZ6
Seizure protein 6 homolog (SEZ6)
Other
1 ADC0% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
0SC-011 / ABBV-011 (SC17, SEZ6, calicheamicin)Calicheamicin
full details →
CD74
HLA class II histocompatibility antigen gamma chain (CD74 / invariant chain / Ii)
Other
1 ADC0% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
0STRO-001Maytansinoid
full details →
CLDN6
Claudin-6
Claudin / tight-junction
1 ADC0% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
0TORL-1-23Auristatin
full details →
VTCN1
B7-H4 (B7x; B7S1; VTCN1)
Other
1 ADC0% mean ocular
Eye-tissue target expression
Cornea
-
Conjunctiva
-
RPE
-
Retina
-
0XMT-1660 (Emiltatug ledadotin)Auristatin
full details →
ROR1
ROR1
Receptor tyrosine kinase
1 ADC0% mean ocular
Eye-tissue target expression
Cornea
1.09 %
Conjunctiva
4.09 %
RPE
-
Retina
-
0Zilovertamab vedotinAuristatin
full details →